Sintx Technologies (SINT) FCF Margin Growth (3y) (2016 - 2026)
Sintx Technologies (SINT) FCF Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -2,196.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2,679.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -20.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -472.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sintx Technologies | 17,274.80 | -1.87 Mn | 144,000.00 | 29,551.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29,551.00 |
| Dec 31, 2025 | -50,956.00 |
| Sep 30, 2025 | -54,884.00 |
| Jun 30, 2025 | -38,286.00 |
| Mar 31, 2025 | 227,485.00 |
| Dec 31, 2024 | 156,023.00 |
| Sep 30, 2024 | 176,233.00 |
| Jun 30, 2024 | 241,619.00 |
| Mar 31, 2024 | 272,834.00 |
| Dec 31, 2023 | 160,156.00 |
| Sep 30, 2023 | 293,155.00 |
| Jun 30, 2023 | 11,451.00 |
| Mar 31, 2023 | 69,882.00 |
| Dec 31, 2022 | 30,664.00 |
| Sep 30, 2022 | 26,483.00 |
| Jun 30, 2022 | -23,406.00 |
| Mar 31, 2022 | -89,186.00 |
| Jun 30, 2021 | -253,364.00 |
| Mar 31, 2021 | -304,978.00 |
| Dec 31, 2020 | -187,867.00 |